Focal Medical appoints Michael Aldridge as CEO
Focal Medical, Inc. (formerly Advanced Chemotherapy Technologies, Inc.), a privately held, biopharmaceutical company developing novel therapeutic products based on its innovative local drug delivery technology platform, recently announced the appointment of Michael Aldridge as the Company’s new Chief Executive Officer(CEO). Michael joins Focal Medical with more than 25 years of experience in the biopharma industry. He […]
